ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Evaluation of the adult with polyarticular pain

Evaluation of the adult with polyarticular pain
Literature review current through: Jan 2024.
This topic last updated: Sep 14, 2022.

INTRODUCTION — Polyarticular pain in an adult is encountered frequently in clinical practice. The causes include various self-limited illnesses and others that are potentially disabling and life-threatening. The history and physical examination generally provide the most useful diagnostic information; supporting or confirmatory data are obtained from laboratory and imaging studies or, more rarely, from tissue biopsy. A complete history and physical examination are appropriate for all patients presenting with polyarticular joint pain, since this symptom may be the initial manifestation of a systemic illness.

The list of causes of polyarticular pain is lengthy [1-3] and includes:

Inflammatory polyarthritis (table 1)

Viral arthritis/arthralgias (table 2)

Postinfectious or reactive arthritis

Osteoarthritis

Fibromyalgia

Multiple sites of bursitis or tendinitis

Soft tissue abnormalities

Hypothyroidism

Neuropathic pain

Metabolic bone disease

Depression

The diagnostic possibilities can be narrowed substantially depending upon whether or not arthritis is present (algorithm 1). Among those in whom there are symptoms and signs of synovitis, the further evaluation is limited to those diseases which cause polyarthritis. In the absence of clear-cut arthritis, the focus shifts to nonarticular sources of pain.

Despite the lengthy list of diseases that cause polyarthritis, most patients with inflammatory arthritis appear to have only one of a few possible disorders. Among over 200 patients with early synovitis (defined as less than one-year duration) evaluated at one academic center, 60 percent were diagnosed with either rheumatoid arthritis (RA) or a spondyloarthropathy at presentation or during the following year [4]. The prognosis is relatively good for those who remain unclassifiable, with nearly one-half of such patients undergoing remission and not requiring any pharmacologic therapy at follow-up at one year.

This topic review will address polyarticular joint pain in adults. Evaluations of the adult with monoarticular pain and of children with joint pain are presented separately. (See "Monoarthritis in adults: Etiology and evaluation" and "Evaluation of the child with joint pain and/or swelling".)

HISTORY — Although the information obtained in the history is seldom sufficient to lead to a specific diagnosis, it allows substantial reduction in reasonable options. An acute presentation with migratory arthritis and fever, for example, is characteristic of rheumatic fever, disseminated gonococcal infection, and viral arthritis.

Musculoskeletal emergencies — The evaluation of polyarticular pain begins by ruling out potential musculoskeletal emergencies. These conditions generally have an acute presentation and are more commonly associated with monoarticular or oligoarticular pain. Some of these emergencies, however, can be seen in patients with polyarticular pain, and failure to make the correct diagnosis could lead to permanent harm to the patient. Important historical points include the following [2]:

Hot or swollen joints may suggest infection (although bacterial infection more commonly presents with acute monoarthritis).

Constitutional symptoms (fever, weight loss, malaise) are nonspecific but raise the suspicion of infection or sepsis.

Joint pain greater than expected from physical findings may be a symptom of a compartment syndrome.

Burning pain, numbness, or paresthesia may suggest an acute myelopathy, radiculopathy, or neuropathy.

Joint symptoms — It is important to obtain a detailed history of the character of the joint pain, including pain quality, time of onset, exacerbating or remitting factors, and duration.

The quality of the pain may be useful in distinguishing musculoskeletal from neurologic causes. The latter is suggested when pain is "burning" or is accompanied by numbness or paresthesias. Neuropathic pain is also likely to be constant, to be intensified at night, and to be unrelated to motion. However, an individual patient may experience more than one type of pain. As an example, patients with rheumatoid arthritis (RA) frequently have neuropathic pain due to carpal tunnel syndrome.

The two main categories of arthritis, inflammatory and noninflammatory, can often be distinguished based upon the character and distribution of joint pain:

With inflammatory arthritis, symptoms tend to worsen with immobility; this accounts for the typical morning stiffness and "gelling" that typically accompanies inflammatory arthritis.

In contrast, the pain of osteoarthritis (OA), the most common type of noninflammatory arthritis, is usually aggravated by motion and weightbearing and is relieved by rest.

The joint involvement in RA is usually symmetrical, whereas asymmetry is frequent in OA, especially in the large joints. Problems such as bursitis, tendinitis, or sprains and strains are also asymmetrical in most cases.

The duration of symptoms may also be helpful. Synovitis that has been present for less than six weeks could represent a viral arthritis or systemic rheumatic disease, whereas a longer duration would increase the likelihood of the latter. The ability to accurately classify patients with early inflammatory arthritis is difficult. In one study of 211 patients with recent-onset synovitis, 36 percent could not be classified and were designated as having "undifferentiated arthropathy" after follow-up of 33 weeks [5]. (See "Undifferentiated inflammatory arthritis in adults" and "Viral arthritis: Causes and approach to evaluation and management".)

Associated symptoms — The presence of extraarticular symptoms may help to narrow the differential diagnosis. Weakness suggests a neurologic or myopathic disorder. On the other hand, signs and symptoms of multisystem involvement (such as fatigue, rash, adenopathy, alopecia, oral and nasal ulcers, pleuritic chest pain, Raynaud phenomenon, or dry eyes and mouth) are common in patients with systemic rheumatic diseases. Fever, night sweats, and weight loss may also suggest systemic illness.

Other clues from the history — The remainder of the history should focus on the usual areas, including past medical history, family history, social history, and system review. Particular attention should be paid to the following:

Functional capacity – This includes assessing the patient's ability to perform usual activities of daily living. Changes in functional status may lead to depression, anxiety, and loss of independence.

History of joint injury – A past medical history of previous trauma, fracture, or surgical procedures on symptomatic joints may help identify the cause of pain.

Risk factors for or a history of infection – For example, exposure to or past infection with viral hepatitis may suggest the diagnosis of viral arthralgia. Exposure to ticks or young children may suggest Lyme disease or parvovirus infection, respectively.

A complete medication list – A review of medications may lead to a specific diagnosis, such as drug-induced lupus or inflammatory polyarthritis due to a checkpoint inhibitor [6], or may alter treatment choices.

Psychologic state and social support system – The more chronic conditions can greatly affect the life of the patient and his or her family.

PHYSICAL SIGNS — After a complete history, the physical examination is used to further narrow the differential diagnosis. As an example, acute lower-extremity pain may have many causes; however, septic arthritis, crystal-induced arthritis, or fracture should be suspected when the pain results in inability to bear weight, or is associated with soft tissue swelling and other signs of inflammation extending far above or below the involved joint.

Joint examination — An important objective of the physical examination is to establish the presence or absence of synovitis [2]. Detecting synovitis substantially increases the likelihood of an inflammatory arthritis or systemic rheumatic disease. The hallmarks of synovitis include:

Soft tissue swelling

Warmth over a joint

Joint line tenderness to palpation

Joint effusion

Loss of motion

Reduced active range of motion with preserved passive range of motion suggests soft tissue disorders such as bursitis, tendinitis, or muscle injury. If both active and passive ranges of motion are decreased, soft tissue contracture, inflammatory or noninflammatory joint disease, or a structural abnormality of the joint should be considered [2].

Joint examination is also critical to confirm the presence of bony enlargement or crepitus, as is typical of osteoarthritis (OA).

General examination — Findings on general examination may point to a systemic condition. These findings include lymphadenopathy, parotid enlargement, oral ulcerations, heart murmurs, pericardial or pleural friction rubs, or fine inspiratory rales due to interstitial lung disease.

Fever suggests a subset of infectious and rheumatic illnesses including [1]:

Infectious arthritis

Postinfectious or reactive arthritis (post-enteric infection, rheumatic fever)

Systemic rheumatic disease, including Still's disease, vasculitis, or systemic lupus erythematosus (SLE)

Crystal-induced arthritis (gout and calcium pyrophosphate crystal deposition [CPPD] disease)

Other diseases such as cancer, sarcoidosis, and mucocutaneous disorders

Additional findings may suggest a specific disease process. Examples of such findings include:

The presence of subcutaneous nodules may be due to rheumatoid nodules or tophi.

Skin lesions may suggest that the joint symptoms are due to infective endocarditis, psoriatic arthritis, SLE, viral infection, or Still's disease.

Eye disease, including keratoconjunctivitis sicca, uveitis, conjunctivitis, and episcleritis, is also a feature of certain rheumatic illnesses.

Concomitant axial pain or stiffness suggests the possibility of axial spondyloarthritis or another seronegative spondyloarthritis. As a result, spinal tenderness, deformity, and range of motion should always be ascertained in patients with polyarticular joint pain.

Complaints of widespread musculoskeletal pain, soft tissue tender points, and prominent somatic symptoms (such as fatigue or cognitive disturbance) characteristic of fibromyalgia are particularly important to identify in patients who have no objective abnormalities in the joints (see "Clinical manifestations and diagnosis of fibromyalgia in adults"). However, joint tenderness may occur in some fibromyalgia patients, and patients with various types of polyarthritis, including rheumatoid arthritis (RA) and SLE, may have superimposed fibromyalgia.

LABORATORY STUDIES — Laboratory studies are not always necessary to make a diagnosis and, in fact, can be misleading. As an example, some patients with osteoarthritis (OA) may have abnormal results that actually reflect other unrelated conditions. In addition, in some patients with arthralgias and myalgias without physical findings, managing symptoms and carefully following the patient over several weeks may be more prudent than an initial battery of tests. Laboratory testing is also unnecessary when a mechanical problem has been identified [2].

When the initial history and physical exam do not yield a diagnosis, however, some diagnostic testing may be indicated. Standard hematologic tests, urinalysis, and biochemical tests (renal and liver function) may help to identify patients with systemic illnesses. Other more specialized tests are discussed below.

Erythrocyte sedimentation rate and C-reactive protein — Nonspecific indicators of inflammation, such as the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP), may be helpful in distinguishing between inflammatory and noninflammatory conditions. However, these tests are never diagnostic and may be abnormal in a vast array of infectious, malignant, rheumatic, and other diseases [7]. The CRP is sometimes a more reliable indicator of the acute phase response than the ESR [8], as the latter may be influenced by abnormal red blood cell morphology and a host of other factors [7]. (See "Acute phase reactants".)

Furthermore, there are numerous examples of the ESR yielding results that are not consistent with the actual rheumatologic process:

Some patients with an inflammatory rheumatic disease have a normal ESR. As an example, in one series of 9135 patients with active rheumatoid arthritis (RA), the ESR was normal in 70 percent, and the CRP was normal in 71 percent [9].

In noninflammatory arthritis, the ESR may be elevated because of another problem, such as renal failure, diabetes, hyperlipoproteinemia, dysproteinemia, or occult malignancy.

The ESR may increase with age in the general population [10]. This phenomenon may be the basis for apparent ESR elevations in some OA patients.

Despite these limitations, the ESR and/or CRP may provide useful clinical information when a certain diagnosis is favored based upon the history and physical findings. In an older patient with aching and stiffness in the hip and shoulder girdle areas, for example, the post-test probability of polymyalgia rheumatica increases if the ESR or CRP is markedly elevated. However, normal inflammatory tests do not preclude the diagnosis.

Antibody tests — Antibody tests can identify exposure to potential pathogens (group A streptococcus, viruses such as parvovirus or hepatitis B and C, Borrelia burgdorferi) (see "Viral arthritis: Causes and approach to evaluation and management"). In addition, certain autoantibodies are associated with a limited group of illnesses and may add diagnostic specificity to a clinical suspicion of rheumatic disease (such as anti-native deoxyribonucleic acid [DNA] or anti-Sm in systemic lupus erythematosus [SLE]) (see "Antibodies to double-stranded (ds)DNA, Sm, and U1 RNP"). These antibody tests should not be ordered routinely but should be reserved for cases in which there is a reasonable clinical suspicion [11] (see below). The indiscriminate use of panels of these tests will result in a high frequency of false-positive results and in additional expensive and unnecessary testing [11-13].

Antinuclear antibody — The antinuclear antibody (ANA) test has high sensitivity but low specificity for SLE. Therefore, unless another cause is evident, it is generally appropriate to order an ANA in patients with polyarthritis since a negative test essentially rules out a diagnosis of SLE. A positive ANA may occur, however, in many rheumatic and nonrheumatic illnesses as well as in healthy individuals. Thus, a patient with few or no clinical features of SLE is unlikely to have the disease, even in the presence of a positive ANA. (See "Measurement and clinical significance of antinuclear antibodies".)

Additional information may help clarify the meaning of a positive ANA. The higher the ANA titer, the more likely that the patient has either SLE or another ANA-associated disease [2]. Additional serologic tests, such as anti-double-stranded (ds)DNA antibodies, may be diagnostic or at least may further limit the differential diagnosis.

Rheumatoid factor — Rheumatoid factor should be ordered when RA is suspected due to signs or symptoms of inflammatory arthritis; however, the test has limited diagnostic value [14]. Approximately one-third of patients with RA remain seronegative throughout their course [14]. Furthermore, patients with other inflammatory or infectious diseases (such as SLE, infective endocarditis, vasculitis, viral infection) may have a positive test (table 3). High rheumatoid factor titers have a better predictive value for the diagnosis of RA and may also predict poor outcomes. (See "Rheumatoid factor: Biology and utility of measurement".)

Antibodies to citrullinated peptides — Anti-citrullinated peptide/protein antibodies (ACPA) are frequently found in patients with RA. ACPA, detected by anti-cyclic citrullinated peptide (anti-CCP) antibody testing, are more specific than rheumatoid factor for diagnosing RA and may predict erosive disease more effectively [15,16]. (See "Biologic markers in the assessment of rheumatoid arthritis", section on 'Anti-citrullinated peptide antibodies'.)

Serum uric acid concentration — Serum uric acid levels are usually elevated in gout, but, since asymptomatic hyperuricemia has a high prevalence in the general population, the finding of hyperuricemia has little diagnostic value. In addition, normal uric acid levels are fairly common during an attack of gout, including in patients with polyarticular involvement [17,18]. The finding of a uric acid level below the lower limit of the normal reference range would make the diagnosis of gout much less likely.

Synovial fluid analysis — Synovial fluid analysis may be diagnostic in patients with bacterial infections or crystal-induced synovitis. Synovial fluid analysis is also valuable to permit classification into an inflammatory or noninflammatory category or to identify hemarthrosis. Patients with established rheumatic disease present a particular challenge as it may be difficult to distinguish a flare of the underlying disease from a new, concomitant disorder, including infectious arthritis. While the American College of Rheumatology (ACR) clinical guidelines suggest that synovial fluid analysis be performed in the febrile patient with an acute flare of established arthritis [2], such testing can be recommended for any patient, with or without prior rheumatic disease, when the diagnosis is uncertain after history, physical examination, and standard laboratory tests. This is especially important when crystal-induced arthritis or septic arthritis is suspected. (See "Joint aspiration or injection in adults: Technique and indications".)

The white cell count, differential count, cultures, Gram stain, and polarized light microscopy are the most valuable studies [2,19]. Noninflammatory fluids generally have fewer than 2000 white blood cells/mm3 and less than 75 percent polymorphonuclear leukocytes (table 4) [19]. The ACR guidelines suggest that unexplained inflammatory fluid, particularly in a febrile patient, should be assumed to be infected until proven otherwise. (See "Synovial fluid analysis".)

IMAGING STUDIES — Imaging studies are expensive and are not required routinely in the evaluation of polyarticular pain. Even when useful, it is seldom necessary to obtain radiographs of all involved joints; those joints with the highest yield in the differential diagnosis should be chosen for imaging. As an example, if rheumatoid arthritis (RA) is the suspected diagnosis, erosions are best visualized in the wrist, hand, and foot.

In acute conditions, radiographs usually lack diagnostic specificity and are generally not helpful for patients with new onset of RA, systemic lupus erythematosus (SLE), gout, tendinitis, or bursitis. In several acute settings, however, plain films may be useful. Chondrocalcinosis, for example, may be seen in calcium pyrophosphate deposition (CPPD) disease (see "Clinical manifestations and diagnosis of calcium pyrophosphate crystal deposition (CPPD) disease"). On the other hand, abnormalities of the sacroiliac (SI) joints are the earliest radiographic finding in ankylosing spondylitis and suggest seronegative spondyloarthropathy as the cause of peripheral polyarthritis. Magnetic resonance imaging (MRI) is more sensitive than plain film radiography in detecting early SI joint abnormalities. (See "Diagnosis and differential diagnosis of axial spondyloarthritis (ankylosing spondylitis and nonradiographic axial spondyloarthritis) in adults".)

Plain radiographs may also be helpful in the diagnosis of the following chronic conditions:

In osteoarthritis (OA), plain films can be used not only to confirm the diagnosis but also to assess the severity. Radiographs can, however, be normal in OA, and the finding of radiographic OA may not be related to the patient's symptoms [2].

In RA, marginal erosions in the joint can be diagnostic. MRI or ultrasound may demonstrate synovitis that is subclinical; in addition, they may identify erosions before plain radiographs [20].

Chronic gout may also cause joint erosions, but these often have an "overhanging edge" suggestive of reparative changes that distinguishes them from erosions due to RA [2]. Ultrasound may provide more specific information than conventional radiographs for the diagnosis of gout [21]. Dual-energy computed tomography (DECT) scanning has high specificity for gout but is not available in all clinical settings [22].

In addition to the detection of early erosions in RA and uric acid crystal deposition in gout described above, ultrasound may also be useful in the evaluation of the patient with polyarticular pain [23] by detecting subtle synovitis in RA and other causes of inflammatory polyarthritis [24] and calcium pyrophosphate crystals [25] in patients with suspected CPPD disease. (See "Musculoskeletal ultrasonography: Clinical applications".)

Radionuclide scans and other imaging procedures are occasionally useful in identifying involvement of both relatively inaccessible joints (eg, hip, SI) and bone (eg, malignancy, infection, Paget disease).

TISSUE BIOPSY — In rare instances, the correct diagnosis in a patient with polyarticular pain requires a tissue biopsy. As an example, synovial biopsy may be useful in the diagnosis of tuberculosis, fungal infection, and sarcoidosis. Biopsy of other tissues may help establish the presence of rheumatoid nodules, Whipple's disease, vasculitis, and hemochromatosis.

DISEASE COURSE — Although it may not be possible to make a definitive diagnosis at the time of a patient's initial presentation with polyarticular pain, some progress has been made in predicting the disease course for those with definite polyarthritis of recent onset. A combination of clinical, laboratory, and imaging data can help to differentiate patients likely to have self-limited disease from those likely to have persistent arthritis. Prediction models based upon patients with early arthritis have identified a number of features associated with persistent and/or erosive disease, including [26-29]:

Duration of symptoms prior to presentation

Older age

Male sex

High BMI

Duration of morning stiffness

Number of tender or swollen joints

Involvement of lower extremities

Elevated acute phase reactants

Rheumatoid factor

Anti-cyclic citrullinated peptide antibody

Erosive change on baseline radiograph

Human leukocyte antigen (HLA)-DRB1 shared epitope alleles

INFORMATION FOR PATIENTS — UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5th to 6th grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10th to 12th grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.

Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)

Beyond the Basics topics (see "Patient education: Arthritis (Beyond the Basics)")

SUMMARY

General approach to polyarticular joint pain – When the history and physical examination are used in concert with selected sequential laboratory and imaging studies, the cause of polyarticular joint pain can be identified in most cases. The American College of Rheumatology (ACR) guidelines make the following general recommendations after completion of a thorough history and physical examination (algorithm 1):

Presence of synovitis

->6 weeks' duration – In the presence of synovitis and symptoms greater than six weeks in duration, consider rheumatoid arthritis (RA) and other systemic rheumatic diseases (table 1). A complete blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor, anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), plasma creatinine concentration, and urinalysis should be obtained. Joint aspiration should be considered if an effusion is present and if the diagnosis is uncertain, especially if septic or crystal-induced arthritis is suspected.

-<6 weeks' duration – In the presence of synovitis and symptoms less than six weeks in duration, a complete blood count, measures of liver function tests, and, in some cases, serologic testing for hepatitis B and C and parvovirus may be helpful (table 2).

Absence of synovitis – In the absence of synovitis, the physical examination finding of tender points suggests fibromyalgia or multiple sites of bursitis or tendinitis; further diagnostic testing may not be needed. (See "Clinical manifestations and diagnosis of fibromyalgia in adults".)

In the absence of synovitis and tender points, consider the remainder of the differential diagnosis (algorithm 1) and consider liver function tests, hepatitis B and C serology, radiographs, and serum levels of thyrotropin (TSH), calcium, albumin, and alkaline phosphatase. When synovitis is suspected by the clinical presentation but cannot be confirmed by physical examination, ultrasound or MRI may be useful techniques to detect subclinical synovitis or erosions. (See 'Imaging studies' above.)

Disease course – A combination of clinical, laboratory, and imaging data can help to differentiate patients likely to have self-limited disease from those likely to have persistent arthritis. Close follow-up will typically reveal the diagnosis. (See 'Disease course' above.)

ACKNOWLEDGMENT — The UpToDate editorial staff acknowledges Robert Pinals, MD, who contributed to an earlier version of this topic review.

  1. Pinals RS. Polyarthritis and fever. N Engl J Med 1994; 330:769.
  2. Guidelines for the initial evaluation of the adult patient with acute musculoskeletal symptoms. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis Rheum 1996; 39:1.
  3. Pujalte GG, Albano-Aluquin SA. Differential Diagnosis of Polyarticular Arthritis. Am Fam Physician 2015; 92:35.
  4. El-Gabalawy HS, Duray P, Goldbach-Mansky R. Evaluating patients with arthritis of recent onset: studies in pathogenesis and prognosis. JAMA 2000; 284:2368.
  5. El-Gabalawy HS, Goldbach-Mansky R, Smith D 2nd, et al. Association of HLA alleles and clinical features in patients with synovitis of recent onset. Arthritis Rheum 1999; 42:1696.
  6. Ghosh N, Tiongson MD, Stewart C, et al. Checkpoint Inhibitor-Associated Arthritis: A Systematic Review of Case Reports and Case Series. J Clin Rheumatol 2021; 27:e317.
  7. Sox HC Jr, Liang MH. The erythrocyte sedimentation rate. Guidelines for rational use. Ann Intern Med 1986; 104:515.
  8. Kushner I. C-reactive protein in rheumatology. Arthritis Rheum 1991; 34:1065.
  9. Kay J, Morgacheva O, Messing SP, et al. Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year. Arthritis Res Ther 2014; 16:R40.
  10. Miller A, Green M, Robinson D. Simple rule for calculating normal erythrocyte sedimentation rate. Br Med J (Clin Res Ed) 1983; 286:266.
  11. Sox HC Jr. Probability theory in the use of diagnostic tests. An introduction to critical study of the literature. Ann Intern Med 1986; 104:60.
  12. Woolf SH, Kamerow DB. Testing for uncommon conditions. The heroic search for positive test results. Arch Intern Med 1990; 150:2451.
  13. Juby A, Johnston C, Davis P. Specificity, sensitivity and diagnostic predictive value of selected laboratory generated autoantibody profiles in patients with connective tissue diseases. J Rheumatol 1991; 18:354.
  14. Shmerling RH, Delbanco TL. How useful is the rheumatoid factor? An analysis of sensitivity, specificity, and predictive value. Arch Intern Med 1992; 152:2417.
  15. Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007; 146:797.
  16. Whiting PF, Smidt N, Sterne JA, et al. Systematic review: accuracy of anti-citrullinated Peptide antibodies for diagnosing rheumatoid arthritis. Ann Intern Med 2010; 152:456.
  17. Hadler NM, Franck WA, Bress NM, Robinson DR. Acute polyarticular gout. Am J Med 1974; 56:715.
  18. Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol 2009; 36:1287.
  19. Shmerling RH, Delbanco TL, Tosteson AN, Trentham DE. Synovial fluid tests. What should be ordered? JAMA 1990; 264:1009.
  20. Baillet A, Gaujoux-Viala C, Mouterde G, et al. Comparison of the efficacy of sonography, magnetic resonance imaging and conventional radiography for the detection of bone erosions in rheumatoid arthritis patients: a systematic review and meta-analysis. Rheumatology (Oxford) 2011; 50:1137.
  21. Howard RG, Pillinger MH, Gyftopoulos S, et al. Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers. Arthritis Care Res (Hoboken) 2011; 63:1456.
  22. Choi HK, Burns LC, Shojania K, et al. Dual energy CT in gout: a prospective validation study. Ann Rheum Dis 2012; 71:1466.
  23. Kaeley GS, Bakewell C, Deodhar A. The importance of ultrasound in identifying and differentiating patients with early inflammatory arthritis: a narrative review. Arthritis Res Ther 2020; 22:1.
  24. Ramírez J, Ruíz-Esquide V, Pomés I, et al. Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers. Arthritis Res Ther 2014; 16:R5.
  25. Gamon E, Combe B, Barnetche T, Mouterde G. Diagnostic value of ultrasound in calcium pyrophosphate deposition disease: a systematic review and meta-analysis. RMD Open 2015; 1:e000118.
  26. Visser H, le Cessie S, Vos K, et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46:357.
  27. Alves C, Luime JJ, van Zeben D, et al. Diagnostic performance of the ACR/EULAR 2010 criteria for rheumatoid arthritis and two diagnostic algorithms in an early arthritis clinic (REACH). Ann Rheum Dis 2011; 70:1645.
  28. Ha YJ, Park YB, Son MK, et al. Predictive factors related to progression toward rheumatoid arthritis in Korean patients with undifferentiated arthritis. Rheumatol Int 2012; 32:1555.
  29. de Rooy DP, van der Linden MP, Knevel R, et al. Predicting arthritis outcomes--what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 2011; 50:93.
Topic 1821 Version 26.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟